Arm Holdings Downgraded by Morgan Stanley; Shares Drop 6% on AI Chip Risks
Morgan Stanley lowered its rating on Arm Holdings to Equal-Weight from Overweight, triggering a roughly 6% stock decline. The analyst flagged the structural shift into chipmaking, extended ramp for AI CPUs, higher R&D costs weighing on margins and potential channel conflict with existing licensees as key risks.
1. Morgan Stanley Rating Cut and Share Reaction
Morgan Stanley lowered Arm Holdings to an Equal-Weight rating from Overweight, sending the stock down about 6% in a single trading session. The downgrade reflects caution on the company’s transition from licensing to in-house chip production and its evolving business model.
2. Ramp-Up Timeline and Margin Pressures
The firm highlighted that commercial adoption of Arm’s new AI-focused CPU design could take longer than anticipated, delaying meaningful chip revenue. At the same time, higher research and engineering expenses are expected to compress margins before the company scales its silicon production.
3. Structural Shift and Channel Conflict Risks
Moving into silicon manufacturing positions Arm to capture more value but pits it against its existing licensees, raising the likelihood of pushback. Investors are weighing the long-term upside of an AI-optimized CPU roadmap against near-term commercial and partnership challenges.